Bill > S917

This bill allows for the expedited approval of generic prescription drugs and the temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages. Specifically, the bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Secretary of Health and Human Services to temporarily allow the importation of certain prescription drugs for up to 3 years if there is a drug shortage. The bill also defines a "marginally competitive market" for certain drugs and requires the Secretary to treat such markets as creating a drug shortage, allowing for expedited review and temporary importation. Additionally, the bill requires the Secretary to report annually on the number of drugs authorized for temporary importation.